Literature DB >> 28362032

Randomized, comparative study of the effectiveness of three different techniques of interscalene brachial plexus block using 0.5% ropivacaine for shoulder arthroscopy.

Michał Kolny, Michał J Stasiowski1, Marek Zuber, Radosław Marciniak, Ewa Chabierska, Aleksandra Pluta, Przemysław Jałowiecki, Tomasz Byrczek.   

Abstract

BACKGROUND: Interscalene brachial plexus block is an effective regional anesthesia technique for shoulder surgeries. The superiority of the popular ultrasound-guided blocks over peripheral nerve stimulator-confirmed blocks remains unclear. In this study the efficacy of these different block techniques was compared.
METHODS: This prospective, randomized, clinical study included 109 patients (ASA grades I-III) who receive 20 mL 0.5% ropivacaine with ultrasound-guided blocks (U group), peripheral nerve stimulator-confirmed blocks (N group), or ultrasound-guided and peripheral nerve stimulator-confirmed blocks (dual guidance; NU group) for elective shoulder arthroscopy. Block onset time, duration, and effectiveness on the Lovett rating scale were assessed.
RESULTS: There was no statistically significant intergroup difference in duration of block performance, irrespective of the technique (P = 0.232). Onset time of complete warmth sensation loss (P < 0.001) and muscle strength abolition (P < 0.001) was significantly longer and mean Lovett rating scale score distribution was significantly higher in the N group than in the other groups (P < 0.001). These findings show a statistically significant correlation between the performance of the used block technique and the necessity of conversion to general anesthesia because of insufficient block in the N group (58.54%) than in the U (24.44%) and NU (19.57%) groups.
CONCLUSIONS: Peripheral nerve stimulator-confirmed needle placement is not necessary to ensure effectiveness of ultrasound-guided blocks, which is expressed as a lack of necessity of conversion to general anesthesia. Nevertheless, the dual guidance technique is recommended to reduce the risk of complications and might be considered the regional anesthesia of choice for shoulder surgery.

Entities:  

Keywords:  Lovett’s Rating Scale; brachial plexus; interscalene brachial plexus block; local anaesthetic; peripheral nerve stimulator; ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28362032     DOI: 10.5603/AIT.2017.0009

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  5 in total

Review 1.  Regional anesthesia to ameliorate postoperative analgesia outcomes in pediatric surgical patients: an updated systematic review of randomized controlled trials.

Authors:  Mark C Kendall; Lucas J Castro Alves; Edward I Suh; Zachary L McCormick; Gildasio S De Oliveira
Journal:  Local Reg Anesth       Date:  2018-11-15

2.  Dose-response studies of Ropivacaine in blood flow of upper extremity after supraclavicular block: a double-blind randomized controlled study.

Authors:  Ting Li; Qiguang Ye; Daozhu Wu; Jun Li; Jingui Yu
Journal:  BMC Anesthesiol       Date:  2017-12-02       Impact factor: 2.217

3.  Ultrasound Imaging of Brachial and Antebrachial Fasciae.

Authors:  Carmelo Pirri; Diego Guidolin; Caterina Fede; Veronica Macchi; Raffaele De Caro; Carla Stecco
Journal:  Diagnostics (Basel)       Date:  2021-12-02

4.  The Effect of Intravenous Dexamethasone and Dexmedetomidine on Analgesia Duration of Supraclavicular Brachial Plexus Block: A Randomized, Four-Arm, Triple-Blinded, Placebo-Controlled Trial.

Authors:  Boohwi Hong; Chahyun Oh; Yumin Jo; Woosuk Chung; Eunhye Park; Hanmi Park; Seokhwa Yoon
Journal:  J Pers Med       Date:  2021-12-01

5.  Preventive Analgesia, Hemodynamic Stability, and Pain in Vitreoretinal Surgery.

Authors:  Michał Jan Stasiowski; Aleksandra Pluta; Anita Lyssek-Boroń; Magdalena Kawka; Lech Krawczyk; Ewa Niewiadomska; Dariusz Dobrowolski; Robert Rejdak; Seweryn Król; Jakub Żak; Izabela Szumera; Anna Missir; Przemysław Jałowiecki; Beniamin Oskar Grabarek
Journal:  Medicina (Kaunas)       Date:  2021-03-12       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.